Quick Answer
Zentalis Pharmaceuticals, Inc. reported Total Assets of $288.97 million for fiscal year 2025.
Zentalis Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $288.97M | -32.9% |
| 2024 | $430.34M | -22.0% |
| 2023 | $551.69M | +2.3% |
| 2022 | $539.31M | +18.7% |
| 2021 | $454.51M | +24.3% |
| 2020 | $365.56M | +317.9% |
| 2019 | $87.48M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $327.25M | -27.4% | -7.0% |
| June 30, 2025 | $351.71M | -28.5% | -8.4% |
| March 31, 2025 | $384.02M | -31.1% | -10.8% |
| December 31, 2024 | $430.34M | -22.0% | -4.5% |
| September 30, 2024 | $450.66M | -23.1% | -8.3% |
| June 30, 2024 | $491.68M | -20.9% | -11.8% |
| March 31, 2024 | $557.48M | +13.9% | +1.0% |
| December 31, 2023 | $551.69M | +2.3% | -5.8% |
- Zentalis Pharmaceuticals, Inc. showed a decrease of -32.9% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Zentalis Pharmaceuticals, Inc.’s total assets has grown by 230.3% (from $87.48 million to $288.97 million).
- The most recent figure is from Zentalis Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: